Figure 13 Ganaxolone (3-hydroxy-3-methyl-5-pregnane-20-one), an orally bioavailable synthetic analog of ALLO, is a positive allosteric modulator of GABA A R with promising basic and early-stage clinical outcomes as a potential novel treatment for PTSD (388, 390392)
Verification: Every batch is SSEA-3 verified , confirming Muse cell identity
National Center for Biotechnology Information (NCBI)
However, patients with low BSA psoriasis and burdensome symptoms who are candidates for biologic therapy (according to the clinicians judgement) may not meet a payers criteria for eligibility to receive advanced psoriasis treatment options [4, 9, 23, 28] Current International Psoriasis Council (IPC), American Academy of Dermatology, and National Psoriasis Foundation treatment guidelines recommend that indicators of psoriasis disease burden beyond BSA, including involvement of high-impact sites and failure of topical therapies, be considered when determining whether patients are eligible for systemic treatment [3, 4]
Mao J, Yang T, Gu Z, Heird WC, Finegold MJ, Lee B, et al
Molecular targets and anticancer potential of indole-3-carbinol and its derivatives